Insider Shareholders with Direct Ownership of Kala Pharmaceuticals, Inc. (KALA)
This section provides a comprehensive overview of the insiders with direct ownership of Kala Pharmaceuticals, Inc. (KALA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kala Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Mark T Iwicki
CHIEF EXECUTIVE OFFICER |
540,888 | 80,535 | 263,755 $1.8 Million | 15 |
Jun 26, 2024
Reduced 5.44%
|
|
Hongming Chen
CHIEF SCIENTIFIC OFFICER |
140,166 | 38,500 | 204,515 $1.39 Million | 8 |
Oct 27, 2021
Reduced 9.33%
|
| 195,072 | 31,881 | 83,982 $571,917 | 15 |
Jun 26, 2024
Reduced 6.13%
|
|
| 197,656 | 30,428 | 83,040 $565,502 | 15 |
Jun 26, 2024
Reduced 5.31%
|
|
| 150,989 | 18,845 | 68,066 $463,529 | 13 |
Jan 04, 2024
Reduced 1.77%
|
|
|
Mary Reumuth
CHIEF FINANCIAL OFFICER |
148,671 | 24,794 | 60,187 $409,873 | 15 |
Jun 26, 2024
Reduced 6.47%
|
|
Darius Kharabi
CHIEF BUSINESS OFFICER |
356,254 | 6,783 | 59,728 $406,747 | 10 |
Jun 26, 2024
Reduced 7.95%
|
| 20,000 | 0 | 40,000 $272,400 | 1 |
Jun 17, 2021
Added 33.33%
|
|
| 20,000 | 0 | 40,000 $272,400 | 1 |
Jun 17, 2021
Added 33.33%
|
|
| 20,000 | 0 | 20,000 $136,200 | 1 |
Jun 17, 2021
Added 50.0%
|
|
| 37,862 | 0 | 13,922 $94,808 | 4 |
Jun 11, 2024
Added 11.17%
|
|
| 32,990 | 0 | 13,887 $94,570 | 4 |
Jun 11, 2024
Added 9.16%
|
|
| 167,702 | 3 | 13,091 $89,149 | 6 |
Jun 11, 2024
Added 9.66%
|
|
| 30,094 | 0 | 10,894 $74,188 | 4 |
Jun 11, 2024
Added 11.39%
|
|
| 7,924 | 0 | 7,924 $53,962 | 3 |
Jun 11, 2024
Added 15.02%
|
|
| 7,792 | 0 | 7,792 $53,063 | 3 |
Jun 11, 2024
Added 15.23%
|